ArticleOncology letters2014

Lung adenocarcinoma harboring L858R and T790M mutations in epidermal growth factor receptor, with poor response to gefitinib: A case report.

Yue Feng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.